D-0278-2024 Class I Ongoing
FDA drug recall D-0278-2024 was initiated by Denver Solutions, LLC DBA Leiters Health on Dec 28, 2023 and is designated Class I. Reason for recall: Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags. The recall status is ongoing. Affected quantity: 13,920 IV bags.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 7, 2024
- Initiation Date
- Dec 28, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 13,920 IV bags
Product description
FentaNYL citrate PF, 2500 mcg per 250 mL 0.9% Sodium Chloride (10 mcg per mL), Item F3342, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-072-82.
Reason for recall
Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.
Distribution pattern
Nationwide within the United States
Code information
Lot #: 2330988, Exp. Date 01/31/2024; 2331058, Exp. Date 02/18/2024; 2331150, Exp. Date 03/10/2024; 2331231, Exp. Date 03/24/2024; 2331289, Exp. Date 03/30/2024.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0278-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026